Complete Genomics' Shares Soar in April | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of Complete Genomics climbed 83 percent in April, after the firm's CEO presented an update on the company's business at a conference and analysts increased their revenue expectations.

Complete Genomics led all shares in the GenomeWeb Daily News Index, which gained 8 percent amid a strong month for the stock market in general, with the Dow Jones Industrial Average up 4 percent, the Nasdaq up 3 percent, and the Nasdaq Biotech Index up 7 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.